Advenica Q2’23 - Strong topline, investing for future growth
2023-07-24 11:30:00
Redeye states that Advenida’s Q2 report was stronger than our estimates on topline. Net revenue was up 15% y/y to SEK31m. Following customer-driven projects Advenicas R&D spending increases and therefore we lower our operating margin in the short term.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/